SEQUENT SCIENTIFIC LTD. - Announcement under Regulation 30 (LODR)-Preferential Issue

Download	< Back
07 Nov 2022
Sequent Scientific Limited has informed the Exchange that the Board of Directors of the Company at their meeting held today, have inter alia considered and approved the following: 1. Acquisition of entire 100% stake in Tineta Pharma Private Limited ('Tineta') 2. Issuance of equity shares of face value Rs. 2/- each fully paid up of the Company for a value of Rs. 65,00,00,000/- (Rupees Sixty-Five Crores only), at a price not lower than the floor price 3. Amendment to 'SeQuent Scientific Limited Employees Stock Option Plan, 2020' (ESOP Scheme), subject to approval of the shareholders. 4. Postal Ballot notice.
View all announcements for SEQUENT SCIENTIFIC LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us